{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T21:10:04Z","timestamp":1738271404593,"version":"3.35.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cataract surgeries are increasing annually, making appropriate medical management essential. The routine use of systemic antimicrobial agents for preventing surgical site infections lacks strong evidence and may increase the risk of drug-resistant bacteria and adverse events. This study examined the impact of discontinuing cefazolin (CEZ) administration during the perioperative period of cataract surgery on the incidence of postoperative adverse events and medical costs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Inpatient cataract surgery patients were divided into two groups: the CEZ-use group (April 2021 to March 2022) and the non-CEZ-use group (April 2022 to March 2023). The primary endpoints were the incidence of adverse events and medical costs, while the secondary endpoint was the incidence of endophthalmitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 265 patients were in the CEZ group, and 316 were in the non-CEZ group. Six postoperative adverse events (2.3%, 95% confidence interval: 0.8\u20134.9) occurred in the CEZ group, with an estimated 230 patients (80\u2013490 from the 95% confidence interval) expected to experience adverse events per 10,000 patients using CEZ. The non-CEZ group had no adverse events and reduced drug costs by approximately 46,000 yen. Insurance claim amounts were also reduced. No cases of early postoperative endophthalmitis were observed in either group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Discontinuation of CEZ prophylaxis during the perioperative period of cataract surgery effectively reduced the risk of adverse events. Medical for the period after discontinuing CEZ did not increase.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Retrospectively registered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40780-025-00412-x","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T20:28:01Z","timestamp":1738268881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of discontinuation of cephazolin prophylaxis on the incidence of postoperative adverse events in cataract surgery"],"prefix":"10.1186","volume":"11","author":[{"given":"Kazutaka","family":"Uchida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Takahama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenshiro","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0693-1896","authenticated-orcid":false,"given":"Kazutaka","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"412_CR1","doi-asserted-by":"publisher","unstructured":"Shimada H, Arai S, Nakashizuka H, Hattori T, Yuzawa M. Reduced anterior chamber contamination by frequent surface irrigation with diluted iodine solutions during cataract surgery. Acta Ophtalmologica. 2017;95:e373-e378. https:\/\/doi.org\/10.1111\/aos.13390.","DOI":"10.1111\/aos.13390"},{"key":"412_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10384-020-00746-z","volume":"64","author":"K Matsuura","year":"2020","unstructured":"Matsuura K, Miyazaki D, Sasaki S, Inoue Y, Sasaki Y, Shimizu Y. Conjunctival bacterial flora and antimicrobial susceptibility in bacterial pathogens isolated prior to cataract surgery. Jpn J Ophthalmol. 2020;64:423\u20138. https:\/\/doi.org\/10.1007\/s10384-020-00746-z.","journal-title":"Jpn J Ophthalmol"},{"key":"412_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1600-0420.2005.00377.x","volume":"83","author":"G Wejde","year":"2005","unstructured":"Wejde G. Endophthalmitis following cataract surgery in Sweden: national prospective survey 1999\u20132001. Acta Ophthalmol Scand. 2005;83:7\u201310. https:\/\/doi.org\/10.1111\/j.1600-0420.2005.00377.x.","journal-title":"Acta Ophthalmol Scand"},{"key":"412_CR4","doi-asserted-by":"publisher","unstructured":"Grzybowski A, Schwartz SG, Matsuura K, Tone SO, Arshinoff S, Ng JQ et al. Endophthalmitis Prophylaxis in Catract Surgery: Overview of Current Practice Patterns Around the World. Curr Pharm Des. 2017;23:565\u2013573. https:\/\/doi.org\/10.2174\/1381612822666161216122230.","DOI":"10.2174\/1381612822666161216122230"},{"key":"412_CR5","doi-asserted-by":"publisher","unstructured":"Matsuo T, Iguchi M, Morisato N, Murasako T, Hagiya H. Are Prophylactic Systemic Antibiotics Required in Patients with Cataract Surgery at Local Anesthesia? Int J Environ Res Public Health. 2022;19:15796. https:\/\/doi.org\/10.3390\/ijerph192315796.","DOI":"10.3390\/ijerph192315796"},{"key":"412_CR6","first-page":"940","volume":"57","author":"A Takahashi","year":"2021","unstructured":"Takahashi A, Kobayashi K, Ueda S, Ito T, Onoe M. Efforts to discontinue prophylactic administration of oral third-generation cephalosporins in patients undergoing cataract surgery and the effects of discontinuation. J Japanese Soc Hosp Pharmacists. 2021;57:940\u20134. Japanese.","journal-title":"J Japanese Soc Hosp Pharmacists"},{"key":"412_CR7","unstructured":"Government of Japan. National action plan on antimicrobial resistance (AMR) the government of Japan. 2016;\u20132020. https:\/\/www.mhlw.go.jp\/content\/10900000\/0000138942.pdf. [accessed 4 June 2024]."},{"key":"412_CR8","unstructured":"Government of Japan. National action plan on antimicrobial resistance (AMR) the government of Japan. 2023;\u20132027. https:\/\/www.mhlw.go.jp\/content\/10900000\/001096228.pdf. [accessed 4 June 2024]."},{"key":"412_CR9","doi-asserted-by":"publisher","unstructured":"Gower EW, Lindsley K, Tulenko SE, Nanji AA, Leyngold I, McDonnell P. J. Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. Cochrane Database Syst Rev. 2017;2:CD006364. https:\/\/doi.org\/10.1002\/14651858.CD006364.pub3.","DOI":"10.1002\/14651858.CD006364.pub3"},{"key":"412_CR10","first-page":"309","volume":"68","author":"Joint Committee of the Japan","year":"2020","unstructured":"Joint Committee of the Japan. Society of Chemotherapy and the Japan Society for Surgical Infection Clinical practice guideline for antimicrobial prophylaxis in surgery. Amendment Jpn J Chemother. 2020;68:309\u201320. Japanese.","journal-title":"Amendment Jpn J Chemother"},{"key":"412_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10384-017-0545-6","volume":"62","author":"T Inoue","year":"2018","unstructured":"Inoue T, Uno T, Usui N, Kobayakawa S, Ichihara K, Ohashi Y. Incidence of endophthalmitis and the perioperative practices of cataract surgery in Japan: Japanese prospective Multicenter study for postoperative endophthalmitis after cataract surgery. Jpn J Ophthalmol. 2018;62:24\u201330. https:\/\/doi.org\/10.1007\/s10384-017-0545-6.","journal-title":"Jpn J Ophthalmol"},{"key":"412_CR12","doi-asserted-by":"publisher","unstructured":"Elliman WB, O\u2019Brien W, Strymish J, Itani K, Wyatt C, Gupta K. Association of Duration and Type of Surgical Prophylaxis With Antimicrobial-Associated Adverse Events. 2019; 154: 590\u2013598. https:\/\/doi.org\/10.1001\/jamasurg.2019.0569.","DOI":"10.1001\/jamasurg.2019.0569"},{"key":"412_CR13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.alit.2023.03.006","volume":"72","author":"C Sugizaki","year":"2023","unstructured":"Sugizaki C, Sato S, Yanagida N, Ebisawa M. Analysis of drug-induced anaphylaxis cases using the Japanese adverse drug Event Report (JADER) database-secondary publication. Allergol Int. 2023;72:580\u20137. https:\/\/doi.org\/10.1016\/j.alit.2023.03.006.","journal-title":"Allergol Int"},{"key":"412_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5649\/jjphcs.45.28","volume":"45","author":"K Yoshida","year":"2019","unstructured":"Yoshida K, Yamamoto J, Ohtaki K, Tsuzuki H, Takahashi A, Kando M, et al. Pharmacists\u2019 interventions in the Infection Control Team Reduce Prophylactic Intravenous Antibiotics in cataract surgery. Japanese J Pharm Health Care Sci. 2019;45:28\u201333. Japanese.","journal-title":"Japanese J Pharm Health Care Sci"},{"key":"412_CR15","doi-asserted-by":"publisher","unstructured":"Takazawa T, Horiuchi T, Nagumo K, Sugiyama Y, Akune T, Amano Y et al. The Japanese Epidemiologic Study for Perioperative Anaphylaxis, a prospective nationwide study: allergen exposure, epidemiology, and diagnosis of anaphylaxis during general anaesthesia. Br J Anaesth. 2023;131:159\u2013169. https:\/\/doi.org\/10.1016\/j.bja.2023.02.018.","DOI":"10.1016\/j.bja.2023.02.018"},{"key":"412_CR16","doi-asserted-by":"publisher","unstructured":"Mertes PM, Alla F, Trechot P, Auroy Y, Jougla E. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol. 2011;128:366\u2013373. https:\/\/doi.org\/10.1016\/j.jaci.2011.03.003.","DOI":"10.1016\/j.jaci.2011.03.003"}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-025-00412-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-025-00412-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-025-00412-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T20:28:04Z","timestamp":1738268884000},"score":1,"resource":{"primary":{"URL":"https:\/\/jphcs.biomedcentral.com\/articles\/10.1186\/s40780-025-00412-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["412"],"URL":"https:\/\/doi.org\/10.1186\/s40780-025-00412-x","relation":{},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Kumamoto Shinto General Hospital (Approval number: 2023-J01-002). Due to the retrospective nature of the study, the requirement for consent to participate was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}